These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8089144)

  • 41. Effects of protein kinase C dependent phosphorylation and a familial hypertrophic cardiomyopathy-related mutation of cardiac troponin I on structural transition of troponin C and myofilament activation.
    Kobayashi T; Dong WJ; Burkart EM; Cheung HC; Solaro RJ
    Biochemistry; 2004 May; 43(20):5996-6004. PubMed ID: 15147183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The calcium sensitizer drug MCI-154 binds the structural C-terminal domain of cardiac troponin C.
    Li MX; Gelozia S; Danmaliki GI; Wen Y; Liu PB; Lemieux MJ; West FG; Sykes BD; Hwang PM
    Biochem Biophys Rep; 2018 Dec; 16():145-151. PubMed ID: 30417133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isoform specific interactions of troponin I and troponin C determine pH sensitivity of myofibrillar Ca2+ activation.
    Ball KL; Johnson MD; Solaro RJ
    Biochemistry; 1994 Jul; 33(28):8464-71. PubMed ID: 8031779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using lanthanide ions to align troponin complexes in solution: order of lanthanide occupancy in cardiac troponin C.
    Gay GL; Lindhout DA; Sykes BD
    Protein Sci; 2004 Mar; 13(3):640-51. PubMed ID: 14978304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.
    Pollesello P; Ovaska M; Kaivola J; Tilgmann C; Lundström K; Kalkkinen N; Ulmanen I; Nissinen E; Taskinen J
    J Biol Chem; 1994 Nov; 269(46):28584-90. PubMed ID: 7961805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The presence but not the sequence of the N-terminal peptide in cardiac TnC is important for function.
    Liu W; Dotson DG; Lin X; Mullen JJ; Gonzalez-Garay ML; Lu Q; Putkey JA
    FEBS Lett; 1994 Jun; 347(2-3):152-6. PubMed ID: 8033994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of cardiac troponin C function by the cardiac-specific N-terminus of troponin I: influence of PKA phosphorylation and involvement in cardiomyopathies.
    Baryshnikova OK; Li MX; Sykes BD
    J Mol Biol; 2008 Jan; 375(3):735-51. PubMed ID: 18042489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Free-Energy Surfaces of Two Cardiac Thin Filament Conformational Changes during Muscle Contraction.
    Mason AB; Tardiff JC; Schwartz SD
    J Phys Chem B; 2022 Jun; 126(21):3844-3851. PubMed ID: 35584206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The C terminus of cardiac troponin I is essential for full inhibitory activity and Ca2+ sensitivity of rat myofibrils.
    Rarick HM; Tu XH; Solaro RJ; Martin AF
    J Biol Chem; 1997 Oct; 272(43):26887-92. PubMed ID: 9341121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ca2+-induced conformational transition in the inhibitory and regulatory regions of cardiac troponin I.
    Dong WJ; Robinson JM; Stagg S; Xing J; Cheung HC
    J Biol Chem; 2003 Mar; 278(10):8686-92. PubMed ID: 12511564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium plays distinctive structural roles in the N- and C-terminal domains of cardiac troponin C.
    Brito RM; Krudy GA; Negele JC; Putkey JA; Rosevear PR
    J Biol Chem; 1993 Oct; 268(28):20966-73. PubMed ID: 8407932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The functional significance of the last 5 residues of the C-terminus of cardiac troponin I.
    Gilda JE; Xu Q; Martinez ME; Nguyen ST; Chase PB; Gomes AV
    Arch Biochem Biophys; 2016 Jul; 601():88-96. PubMed ID: 26919894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential pH effect on calcium-induced conformational changes of cardiac troponin C complexed with cardiac and fast skeletal isoforms of troponin I and troponin T.
    Liou YM; Chang JC
    J Biochem; 2004 Nov; 136(5):683-92. PubMed ID: 15632309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant troponin I substitution and calcium responsiveness in skinned cardiac muscle.
    Strauss JD; Van Eyk JE; Barth Z; Kluwe L; Wiesner RJ; Maéda K; Rüegg JC
    Pflugers Arch; 1996 Apr; 431(6):853-62. PubMed ID: 8927501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions.
    Ferrières G; Pugnière M; Mani JC; Villard S; Laprade M; Doutre P; Pau B; Granier C
    FEBS Lett; 2000 Aug; 479(3):99-105. PubMed ID: 10981715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Förster resonance energy transfer structural kinetic studies of cardiac thin filament deactivation.
    Xing J; Jayasundar JJ; Ouyang Y; Dong WJ
    J Biol Chem; 2009 Jun; 284(24):16432-16441. PubMed ID: 19369252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation.
    Biesiadecki BJ; Kobayashi T; Walker JS; Solaro RJ; de Tombe PP
    Circ Res; 2007 May; 100(10):1486-93. PubMed ID: 17446435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The interaction of the bisphosphorylated N-terminal arm of cardiac troponin I-A 31P-NMR study.
    Schmidtmann A; Lohmann K; Jaquet K
    FEBS Lett; 2002 Feb; 513(2-3):289-93. PubMed ID: 11904166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure and proteolytic susceptibility of the inhibitory C-terminal tail of cardiac troponin I.
    Mahmud Z; Zahran S; Liu PB; Reiz B; Chan BYH; Roczkowsky A; McCartney CE; Davies PL; Li L; Schulz R; Hwang PM
    Biochim Biophys Acta Gen Subj; 2019 Apr; 1863(4):661-671. PubMed ID: 30659884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solution structure of the regulatory domain of human cardiac troponin C in complex with the switch region of cardiac troponin I and W7: the basis of W7 as an inhibitor of cardiac muscle contraction.
    Oleszczuk M; Robertson IM; Li MX; Sykes BD
    J Mol Cell Cardiol; 2010 May; 48(5):925-33. PubMed ID: 20116385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.